FTO and cancer: Since the discovery of FTO as the first identified m6A demethylase enzyme in 2011, it has been demonstrated to play a crucial role in influencing cancer progression by removing m6A modifications from downstream target genes in various cancers (Huang et al. 2022; Niu et al. 2019).